COVID-19: NPHCDA crosses 1m vaccination threshold
The National Primary Health Care Development Agency (NPHCDA) said 30,452 Nigerian residents received COVID-19 vaccine injections on Friday, bringing the number of vaccines so far to 1.08 million.
The NPHCDA revealed this on its official Twitter account on Friday.
The agency said 30,452 people took the first dose of the Oxford AstraZeneca vaccine.
“As of April 16, some 1,081,548 representing 53.8% of eligible people targeted by the AstraZeneca vaccine have received their first dose during this phase of vaccination.
“The 1,081,548 were eligible Nigerians who were vaccinated in 36 states and the Federal Capital Territory (FCT),” he said.
The agency said that figure was more than half of the percentage of the goal achieved with the first dose of COVID-19 vaccine in the country.
The vaccination agency revealed that of the 1,081,548 people who received the Oxford-AstraZeneca COVID-19 vaccine in the country, 8,439 people suffered mild adverse reactions after immunization (AEFI).
He added that 52 people had moderate to severe side effects when receiving the injections.
He explained that mild reactions include body pain and swelling, moderate to severe side effects shown were fever, vomiting, headache, diarrhea, dizziness and allergic reactions.
The vaccination agency revealed that there were no deaths due to the administration of the vaccine and “no cases of blood clots related to the administration of the vaccines have been diagnosed in the country”.
He said five states have the highest AEFI records, namely: Kaduna (970); Cross River (859); Yobe (541); Kebbi (511); and Lagos (448).
The NPHCDA said the cases were being investigated to ensure they were due to the vaccination.
According to him, states with coverage above 100% have vaccinated more than 50% of the eligible population required for the first dose.
The NPHCDA said Lagos State exceeded the total number of clients vaccinated in the country by administering 200,602 and Kano with 57,900.
He said they were followed by kaduna, 56,238; while Ogun with 52,906 and the FCT with 46,049 had all received their first dose of Oxford AstraZeneca.
News Agency of Nigeria (NAN) reports that in order for the country to achieve high immunity against COVID-19, it has set itself an ambitious goal of vaccinating 40% of its more than 200 million people before it ends. from 2021.
The country also hopes to reach 70% by the end of 2022.
The country has started vaccination since March 5, 2021, with health workers most at risk of infection being the first responders.
He noted that the vaccine deployment would take place in four phases, starting with health workers, frontline workers, the COVID-19 rapid response team, the laboratory network, police officers, staff of service stations and strategic leaders.
“Phase 2 – Adults aged 50 and over. Those with co-morbidities between the ages of 18 and 49
“Phase 3 – Those in high disease burden states / LGAs who missed phases 1 and 2.
“Phase 4 – Other eligible population as vaccines become available,” it is said.
The immunization agency said as of April 15, 2021, only 1,051,096 vaccines had been administered in 36 states and the Federal Capital Territory (FCT).
He noted that the proportion of eligible people vaccinated in the country was 52.2% as of April 15.
NAN recalls that the country has received 3.94 million doses of Oxford-AstraZeneca vaccine via COVAX, a UN-backed effort that promises access to free vaccines for up to 20% of the population of participating countries.
The delivery is part of a total of 16 million doses that are expected to be delivered to Nigeria in batches over the coming months.
In addition, on March 21, 2021, the country received an additional 300,000 doses of the same vaccines from telecommunications giant MTN.
On April 6, the Indian government also delivered 100,000 doses of Covishield COVID-19 vaccine to Nigeria.
COVISHIELD, a brand of the Oxford AstraZeneca vaccine that is also manufactured, is used in more than 71 countries, including the United Kingdom, Canada, India and Brazil.
With only 4.4 million doses of COVID-19 vaccines available in the country, Nigeria is still a long way from reaching its set target, according to health experts.
Due to the limited doses of vaccine available, the federal government has ordered states to stop immunization once it has used up half of their allotted doses.
The government said the directive became necessary because the country was unsure of when the next batch of AstraZeneca vaccine would arrive in the country.
“We think in a situation where we still can’t specifically determine when the next batch of AstraZeneca vaccine will arrive, then I think wisdom is just telling us that it’s best for us to fully immunize people.
“This is so that we can say that we have a pool of citizens who have been fully vaccinated since this vaccination is available in two doses,” he explained.